Previous close | 19.50 |
Open | 19.20 |
Bid | 19.00 x 300000 |
Ask | 19.30 x 300000 |
Day's range | 19.10 - 19.20 |
52-week range | 19.00 - 71.00 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
DUBLIN, March 05, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.
DUBLIN, March 04, 2024--Prothena today announced that it has named David Ford to a newly created position of Chief People Officer.